Cutaneous wound healing: An update

Journal of Dermatology

Volumn 28, Issue 10, 2001, Pages 521-534

  Yamaguchi, Y ^a   Yoshikawa, K ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Epithelial mesenchymal interactions; Granulation tissue formation; Practical wound management; Re epithelialization; Wound contraction

Indexed keywords

GROWTH FACTOR;

ADIPOCYTE; CELL ACTIVATION; CELL INTERACTION; CELL PROLIFERATION; FIBROBLAST; HUMAN; INFLAMMATION; KERATINOCYTE; LANGERHANS CELL; MELANOCYTE; MYOFIBROBLAST; NERVOUS SYSTEM; OSTEOMYELITIS; REVIEW; SKIN GRAFT; SKIN INJURY; WOUND DRESSING; WOUND HEALING;

EID: 0035196741     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2001.tb00025.x     Document Type: Review

References (117)

1. The wound healing process
2. Wound healing-aiming for perfect skin regeneration
3. Cutaneous wound healing
4. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization
5. Keratinocyte migration and the extracellular matrix
6. Un-cross-linked fibrin substrates inhibit keratinocyte spreading and replication: Correction with fibronectin and factor XIII cross-linking
7. Platelet-derived growth factor
8. Mechanism of action and in vivo role of platelet-derived growth factor
9. Transforming growth factor-β in tissue fibrosis
10. Transforming growth factor βs and wound healing
11. Epidermal growth factor and related molecules
12. Epidermal growth factor and keratinocyte growth factor differentially regulate epidermal migration, growth, and differentiation
13. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice
14. Wound macrophages express TGF-α and other growth factors in vivo: Analysis by mRNA phenotyping
15. Lack of insulin-like growth factor 1 (IGF1) in the basal keratinocyte layer of diabetic skin and diabetic foot ulcers
16. Heparin-binding epidermal growth factor-like growth factor is an autocrine growth factor for human keratinocytes
17. Fibroblast growth factor 2 control of vascular tone
18. Synergism between vascular endothelial growth factor and placental growth factor contributes to angogenesis and plasma extravasation in pathological conditions
19. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse
20. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
21. Mechanisms of angiogenesis and arteriogenesis
22. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the performed endothelial network and is regulated by PDGF-B and VEGF
23. Heterogeneity of normal human diploid fibroblasts: Isolation and characterization of one phenotype
24. Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts
25. Low oxygen stimulates proliferation of fibroblasts seeded as single cells
26. Human dermal fibroblast clones derived from single cells are heterogeneous in the production of mRNAs for α1 (I) procollagen and transforming growth factor-β1
27. Lack of co-ordinate expression of the α1 (I) and α1 (III) procollagen genes in fibroblast clonal cultures
28. The levels and kinetics of oxygen tension detectable at the surface of human dermal fibroblast cultures
29. The transcriptional program in the response of human fibroblasts to serum
30. Involvement of keratinocyte activation phase in cutaneous graft healing: Comparison of fullthickness and split-thickness skin grafts
31. Stem cell patterning and fate in human epidermis
32. Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes
33. β1 integrins regulate keratinocyte adhesion and differentiation by distinct mechanisms
34. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis
35. Skin and hair follicle integrity is crucially dependent on β1 integrin expression on keratinocytes
36. Conditional ablation of β1 integrin in skin: Severe defects in epidermal proliferation, basement membrane formation, and hair follicle invagination
37. Involvement of follicular stem cells in forming not only the follicle but also the epidermis
38. Location of stem cells of human hair follicles by clonal analysis
39. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency
40. The activity of collagenase-1 is requried for keratinocyte migration on a type I collagen matrix
41. Keratinocyte collagenase-1 expression requires an epidermal growth factor receptor autocrine mechanism
42. Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes activity involved in wound healing
43. Expression of matrix metalloproteinase-2 and -9 during early human wound healing
44. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds
45. Distinct populations of stromal cells express collagenease-3 (MMP-13) and collagenase-1 (MMP1) in chronic ulcers but not in normally healing wounds
46. Impaired wound healing in mice with a disrupted plasminogen gene
47. Physiological consequences of loss of plasminogen activator gene function in mice
48. Keratinocytespecific ablation of Stat 3 exhibits imparied skin remodeling, but does not affect skin morphogenesis
49. Two distinct signaling pathways in hair cycle induction: Stat 3-dependent and -independent pathways
50. Tansforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the αvβ6 heterodimer in normal human keratinocytes: Implications for wound healing
51. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16
52. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor
53. Autocrine nerve growth factor in human keratinocytes
54. Direct effects of cutaneous neruopeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: Stimulation of cyclic AMP formation by CGP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors
55. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair
56. Granulation tissue as a contractile organ
57. Evolution and clinical implications of the myofibroblast concept
58. Mechanisms of myofibroblast activity and phenotypic modulation
59. Fibroblasts, myofibroblasts, and wound contraction
60. α-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing
61. Transforming growth factor-β1 induces αsmooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
62. A function for filamentous α-smooth muscle actin: Retardation of motility in fibroblasts
63. Fibronectin and integrins in cell adhesion, signaling, and morphogenesis
64. Fibronectin fibrilogenesis: A paradigm for extracellular matrix assembly
65. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice
66. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar
67. Activated keratinocytes in the epidemis of hypertrophic scars
68. Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression
69. Regulation of keratin 9 in nonpalmoplantar keratinocytes by palmoplantar fibroblasts through epithelial-mesenchymal interactions
70. Epithelial-mesenchymal interactions in wounds: Treatment of palmoplantar wounds by nonpalmoplantar pure epidermal sheet grafts
71. Induction of follicle formation and growth by vibrissa dermal papillae implanted into rat ear wounds: Vibrissa-type fibers are specified
72. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal intteraction in skin
73. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction
74. Neural innervation and healing
75. Effect of electrical nerve stimulation on healing of ischaemic skin flaps
76. Slowing of wound healing by psychological stress
77. Effects of fat cells on keratinocytes and fibroblasts in a reconstructed rat skin model using collagen gel matrix culture
78. Biological action of leptin as an angiogenic factor
79. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig
80. Effect of air exposure and occlusion on experimental human skin wounds
81. Moist wound healing with occlusive dressings: A clinical focus
82. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
83. Grafting of burns with cultured epithelium prepared from autologous epidermal cells
84. Permanent coverage of large burn wounds with autologous cultured human epithelium
85. Treatment of junctional epidermolysis bullosa with epidermal autografts
86. Serial cultivation of single keratinocytes from the outer root sheath of human scalp hair follicles
87. Bioengineered skin
88. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent
89. Enhancment of wound healing by topical treatment with epidermal growth factor
90. Platelet-derived growth factor BB for the treatment of chronic pressure ulcers
91. Quick healing of leg ulcers after molgramostim
92. Effect of topical application of nerve-growth factor on pressure ulcers
93. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores
94. Randomized placebo-controlled trial of use of topical recombinant bovine basic fibroblast growth factor for second-degree burns
95. Sucralfate and chronic venous stasis ulcers
96. Initial management of burns
97. Healing in the irradiated wound
98. Pressure ulcers among the elderly
99. Pressure ulcers
100. Cinical effectiveness of an ointment containing prostaglandin E1 for the treatement of burn wounds
101. Topical haemotherapy for leg ulcers
102. Stanozolol as a novel therapeutic agent in dermatology
103. Stimulation of collagen sythesis by the anabolic steroid stanozolol
104. Stanozolol in treatment of leg ulcers due to cryofibrinogenaemia
105. Stanozolol causes rapid pain relief and healing of cutaneous ulcers caused by cryofibrinogenemia
106. Chronic venous insufficiency and venous leg ulceration
107. Relation between postphlebitic changes in the deep veins and results of surgical treatment of venous ulcers
108. Guidelines for the management of chronic venous leg ulceration: Report of a multidisciplinary workshop
109. Split-thickness skin grafting for lower extremity ulcerations
110. The cause of venous ulceration
111. The 'trap' hypothesis of venous ulceration
112. Factor XIII-mediated inhibition of fibrinolysis and venous leg ulcers
113. Foot ulcers
114. Increased mortality associated with diabetic foot ulcer
115. Assessment and management of foot disease in patients with diabetes
116. Treatment of chronic erosions of junctional epidermolysis bullosa with human epidermal allografts
117. The use of autologous and bioengineered epidermis to control fibrosis and improve cosmesis